Buy Lupin with target of 530: Pankaj Pandey

In a chat with ET Now, Pankaj Pandey, Head of Research, ICICI Direct shares his views on pharma stocks.

ET Now: What is your call on pharma stocks?

Pankaj Pandey: On the positive side, we have pharma, which is still remaining intact as our one of the most bullish sectors. Lupin is also one of the picks with a target price of 530.